Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Recruiting now

Conditions studied: Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predisposition to Disease, Atrial Fibrillation, Myocardial Infarction, Heart Failure

In brief

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Key facts

Study ID

NCT01258231

Run by

Brigham and Women's Hospital

People needed

4000

Starts

2000-08-01

Expected to finish

2030-08-01

Last updated by the study team

2024-08-22

Who can join

Age: 20 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing heart surgery
• Willing to provide consent

You may not qualify if…

• Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

Where it is running

• UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Department Texas Heart Institute at St. Luke's Episcopal Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.